The WACC of Nektar Therapeutics (NKTR) is 8.8%.
| Range | Selected | |
| Cost of equity | 9.50% - 15.70% | 12.60% |
| Tax rate | 0.10% - 0.10% | 0.10% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 7.2% - 10.3% | 8.8% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 1.22 | 1.93 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 9.50% | 15.70% |
| Tax rate | 0.10% | 0.10% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 7.2% | 10.3% |
| Selected WACC | 8.8% | |